Just a moment...

Report
FeedbackReport
Bars
×

By creating an account you can:

Logo TaxTMI
>
Feedback/Report an Error
Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
TMI Blog
Home / RSS

Health services firm SastaSundar to invest Rs 150 cr in 2 yrs, aims turnaround in FY'26

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....ealth services firm SastaSundar to invest Rs 150 cr in 2 yrs, aims turnaround in FY'26<BR>PTI News<BR>Dated:- 20-6-2025<BR>PTI<BR>Kolkata, Jun 20 (PTI) SastaSundar Ventures Ltd is in the process of investing Rs 150 crore over the next two years to strengthen its digital healthcare platform and warehousing infrastructure to make a turnaround and return to profit in FY'26, a company official said on....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

.... Thursday. The investment will largely be funded through a Rs 145-crore capital pool, created from the Flipkart Health exit settlement and internal treasury income. The Kolkata-based online pharmacy ended its partnership with Flipkart Health earlier this year and relaunched its B2C platform under its own brand. "We are aiming to return to net profit in the current fiscal through strategic initi....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....atives. We are focusing on the execution of these and capital-efficient growth to recover the company from a Rs 122 crore net loss in FY'25. "Out of the Rs 150 crore, about Rs 40 crore was deployed in FY'25, and the remaining Rs 110 crore will be invested in FY'26 and FY'27," SastaSundar Chairman B L Mittal told PTI. To tap into the rising demand for affordable medication, SastaSundar has launch....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....ed JITO, a curated generics medicine channel under its main brand. "We expect to invest nearly Rs 25 crore to develop the JITO platform to push retail sales," Mittal said. The concept of quality-verified generic substitutes is gaining popularity, offering customers significant discounts compared to branded prescription drugs. With a Rs 50-crore investment planned in technology and AI-driven hea....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....lthcare tools, the company is targeting to double its B2C business in FY'26, from Rs 144 crore achieved in FY'25. A major portion of this investment will go towards hiring tech and AI talent to build digital consultation, diagnostics, and personal health profiling tools, Mittal recently informed investors in a conference call. On the distribution side, 250 Health Buddies are currently active pos....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....t the Flipkart exit, and the company expects this number to rise to around 400 by the end of FY'26, he said. On the B2B front, RetailerShakti, which supplies to pharmacies, delivered a strong performance with revenue nearly doubling to Rs 941 crore in FY'25, he said. The company is targeting EBITDA breakeven for RetailerShakti in the last quarter of FY'26. By FY'30, SastaSundar aims to achieve ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....a blended EBITDA margin of 4-5 per cent. PTI BSM BDC<BR> News - Press release - PIB....